American research and development arm of Zhejiang Huahai Pharmaceutical, the Chinese maker of active pharmaceutical ingredients and generic finished medicines, based in New Jersey. Carries out formulation and product development for the American generics market, prepares abbreviated new drug applications and other submissions to the Food and Drug Administration, runs analytical and bioequivalence work for the group's products and supports its United States commercial and regulatory operations.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen